These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 14983614)

  • 1. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
    Work DR; Domino ME
    N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
    [No Abstract]   [Full Text] [Related]  

  • 2. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs: budget busters or cost cutters in future health care?
    Egger E
    Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 5. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Menkes DB; Woodall AA
    N Z Bioeth J; 2003 Oct; 4(3):22, 24-5. PubMed ID: 15597480
    [No Abstract]   [Full Text] [Related]  

  • 6. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
    Rai AK
    Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Adams J
    N Z Bioeth J; 2003 Oct; 4(3):22-3. PubMed ID: 15597478
    [No Abstract]   [Full Text] [Related]  

  • 8. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs.
    Cahn LJ
    Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372
    [No Abstract]   [Full Text] [Related]  

  • 9. A few specialty drug prices fall--all generics.
    Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription-drug coupons--no such thing as a free lunch.
    Ross JS; Kesselheim AS
    N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672
    [No Abstract]   [Full Text] [Related]  

  • 12. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
    Ozdemir V; Williams-Jones B
    Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drugs at bargain prices.
    Guglielmo WJ
    Newsweek; 2001 Apr; 137(17):62. PubMed ID: 11338630
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug prices in the US.
    Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
    [No Abstract]   [Full Text] [Related]  

  • 16. Fees-for-services, cost recovery, and equity in a district of Burkina Faso operating the Bamako Initiative.
    Ridde V
    Bull World Health Organ; 2003; 81(7):532-8. PubMed ID: 12973646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saving money on your prescription drugs.
    Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):4-5. PubMed ID: 20336846
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of being first: evidence from Canadian generic pharmaceuticals.
    Hollis A
    Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost of drugs: a policy conundrum of global proportions.
    Barry DR; Romig B
    N C Med J; 2003; 64(6):287-8. PubMed ID: 14983620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.